Safety, pharmacokinetics, and pharmacodynamics study of MK-8389 in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function.

Trial Profile

Safety, pharmacokinetics, and pharmacodynamics study of MK-8389 in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function.

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Feb 2016

At a glance

  • Drugs MK 8389 (Primary)
  • Indications Infertility
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 04 Feb 2016 New trial record
    • 05 Jan 2016 Results published in the Fertility and Sterility
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top